[1. SEN-CHOWDHRY S., JACOBY D., MOON JC., MCKENNA WJ. Update on hypertrophic cardiomyopathy and a guide to the guidelines. Nat Rev Cardiol. 2016; 13(11):651-675.10.1038/nrcardio.2016.140]Search in Google Scholar
[2. ELLIOTT PM., ANASTASAKIS A., BORGER MA., BORGGREFE M., CECCHI F., CHARRON P., et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy. Eur. Heart J. 2014; 35(39):2733-79.10.1093/eurheartj/ehu284]Search in Google Scholar
[3. MARON BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002; 287(10):1308-20.10.1001/jama.287.10.1308]Search in Google Scholar
[4. ELLIOTT P., CHARRON P., BLANES JR., TAVAZZI L., TENDERA M., KONTÉ M., LAROCHE C., et al. European Cardiomyopathy Pilot Registry: EURObservational Research Programme of the European Society of Cardiology. 2016; 37(2):164-73.10.1093/eurheartj/ehv497]Search in Google Scholar
[5. CHARRON P., ELLIOTT PM., GIMENO JR., CAFORIO ALP., KASKI JP., TAVAZZI L., et al. The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies. Eur Heart J. 2018 (doi: 10.1093/eurheartj/ehx819).10.1093/eurheartj/ehx819)]Open DOISearch in Google Scholar
[6. OLIVOTTO I., MARON MS., ADABAG AS., CASEY SA., VARGIU D., LINK MS., et al. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005; 46(3):480-7.10.1016/j.jacc.2005.04.043]Search in Google Scholar
[7. MARON BJ., MARON MS. Hypertrophic cardiomyopathy. Lancet. 2013; 381(9862):242-55.10.1016/S0140-6736(12)60397-3]Search in Google Scholar
[8. OLIVOTTO I., CECCHI F., CASEY SA., DOLARA A., TRAVERSE JH., MARON BJ. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation. 2001; 104(21):2517-24.10.1161/hc4601.097997]Search in Google Scholar
[9. GUTTMANN OP., RAHMAN MS., O’MAHONY C., ANASTASAKIS A., ELLIOTT PM. Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review. Heart. 2014; 100(6):465-72.10.1136/heartjnl-2013-304276]Search in Google Scholar
[10. CECCHI F., OLIVOTTO I., BETOCCHI S., RAPEZZI C., CONTE MR., SINAGRA G., et al. The Italian registry for hypertrophic cardiomyopathy: A nationwide survey. Am Heart J. 2005; 150(5):947-54.10.1016/j.ahj.2005.01.005]Search in Google Scholar
[11. APETREI E., COMAN I., GEORGESCU G., CAPRARU C., PETRE D. Correlation between ECG and echocardiographical changes in 145 cases of hypertrophic cardiomyopathy. Proceedings 14th Int. Congr. Electrocardiol. Berlin, 1997; 591-4.10.1515/9783112484289-130]Search in Google Scholar
[12. MONSERRAT L., ELLIOTT PM., GIMENO JR., SHARMA S., PENAS-LADO M., MCKENNA WJ. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2003; 42(5):873-9.10.1016/S0735-1097(03)00827-1]Search in Google Scholar
[13. ADABAG AS., CASEY SA., KUSKOWSKI MA., ZENOVICH AG., MARON BJ. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. J Am Col. Cardiol. 2005; 45(5):697-704.10.1016/j.jacc.2004.11.043]Search in Google Scholar
[14. MARON MS, OLIVOTTO I, ZENOVICH AG, LINK MS, PANDIAN NG, KUVIN JT, et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation. 2006; 114(21):2232-9.10.1161/CIRCULATIONAHA.106.64468217088454]Search in Google Scholar
[15. TO AC., DHILLON A., DESAI MY. Cardiac magnetic resonance in hypertrophic cardiomyopathy. JACC Cardiovasc Imaging. 2011; 4(10):1123-37.10.1016/j.jcmg.2011.06.02221999873]Search in Google Scholar
[16. O’HANLON R., GRASSO A., ROUGHTON M., MOON JC., CLARK S., WAGE R., et al. Prognostic Significance of Myocardial Fibrosis in Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2010; 56(11):867-74.10.1016/j.jacc.2010.05.01020688032]Search in Google Scholar
[17. SPOLADORE R., MARON MS., D’AMATO R., CAMICI PG., OLIVOTTO I. Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence. Eur Heart J. 2012; 33(14):1724-33.10.1093/eurheartj/ehs15022719025]Search in Google Scholar
[18. APETREI E., SEGGEWISS H., DELEANU D., POPESCU BA., ZARMA L., COMAN IM. Ablaţia miocardică septală percutanată în cardiomiopatia hipertrofică obstructivă. Rev Rom Cardiol. 1991; 9:134-40.]Search in Google Scholar